Company · CIK 1980845

# enGene Therapeutics Inc.

| CIK | [1980845](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001980845) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | Z4 |
| Listed | ENGN (Nasdaq), ENGNW (Nasdaq) |
| First annual or quarterly report | 2024-01-29 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-293597 | Shelf Effective | 2026-02-19 | 2026-03-09 | 3 |
| 333-283201 | Shelf Effective | 2024-11-13 | 2025-11-14 | 5 |
| 333-283202 | Shelf Effective | 2024-11-13 | 2024-11-21 | 2 |
| 333-275700 | First-time registration Effective | 2023-11-22 | 2024-03-05 | 4 |

## Filings

 16

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-03-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1980845/000119312526097563/0001193125-26-097563-index.htm) Shelf takedown | 333-293597 | 0001193125-26-097563 |
| 2026-03-02 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1980845/999999999526000700/9999999995-26-000700-index.htm) Declared effective | 333-293597 | 9999999995-26-000700 |
| 2026-02-19 | [S-3](https://www.sec.gov/Archives/edgar/data/1980845/000119312526059479/0001193125-26-059479-index.htm) Shelf registered | 333-293597 | 0001193125-26-059479 |
| 2025-11-14 | [424B5](https://www.sec.gov/Archives/edgar/data/1980845/000119312525281504/0001193125-25-281504-index.htm) Shelf takedown | 333-283201 | 0001193125-25-281504 |
| 2025-11-12 | [424B5](https://www.sec.gov/Archives/edgar/data/1980845/000119312525277833/0001193125-25-277833-index.htm) Shelf takedown | 333-283201 | 0001193125-25-277833 |
| 2024-12-20 | [424B5](https://www.sec.gov/Archives/edgar/data/1980845/000095017024138766/0000950170-24-138766-index.htm) Shelf takedown | 333-283201 | 0000950170-24-138766 |
| 2024-11-21 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1980845/999999999524003546/9999999995-24-003546-index.htm) Declared effective | 333-283202 | 9999999995-24-003546 |
| 2024-11-21 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1980845/999999999524003545/9999999995-24-003545-index.htm) Declared effective | 333-283201 | 9999999995-24-003545 |
| 2024-11-13 | [S-3](https://www.sec.gov/Archives/edgar/data/1980845/000095017024126454/0000950170-24-126454-index.htm) Shelf registered | 333-283202 | 0000950170-24-126454 |
| 2024-11-13 | [S-3](https://www.sec.gov/Archives/edgar/data/1980845/000095017024126446/0000950170-24-126446-index.htm) Shelf registered | 333-283201 | 0000950170-24-126446 |
| 2024-03-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1980845/999999999524000603/9999999995-24-000603-index.htm) Declared effective | 333-275700 | 9999999995-24-000603 |
| 2024-02-27 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1980845/000119312524046578/0001193125-24-046578-index.htm) Amendment | 333-275700 | 0001193125-24-046578 |
| 2023-12-15 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1980845/000119312523296741/0001193125-23-296741-index.htm) Amendment | 333-275700 | 0001193125-23-296741 |
| 2023-11-22 | [S-1](https://www.sec.gov/Archives/edgar/data/1980845/000119312523281677/0001193125-23-281677-index.htm) Registration filed | 333-275700 | 0001193125-23-281677 |
| 2023-09-29 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1980845/999999999523002876/9999999995-23-002876-index.htm) Declared effective | 333-273851 | 9999999995-23-002876 |
| 2023-06-14 | [DRS](https://www.sec.gov/Archives/edgar/data/1980845/000095012323005719/0000950123-23-005719-index.htm) Draft made public | 377-06746 | 0000950123-23-005719 |

[All filings of this company](https://equitycapital.markets/filings?cik=1980845) · [CSV](https://equitycapital.markets/filings.csv?cik=1980845)

---
Source page: https://equitycapital.markets/company/1980845 · Data: U.S. SEC EDGAR · CC BY 4.0